Munich Scientists Design New Myeloid Malignancy Panel with RainDance Tech Scientists at a leading reference diagnostic laboratory in Germany have developed a panel of genes linked to myeloid malignancies for use with RainDance’s targeted sequencing technology At the MLL Munich Leukemi
Accurate variant detection across non-amplified and whole genome amplified DNA using targeted next generation sequencing Abdou ElSharawy, Jason Warner, Jeff Olson, Michael Forster, Markus B. Schilhabel, Darren Link, Stefan Rose-John, Stefan Schreiber, Philip Rosenstiel, James Brayer,
RainDance Technologies® is making complex genetics simple. The company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases. Major research institutions and laboratories around the world rely on the performance of RainDance systems. Based outside Boston, Massachusetts, the company supports customers using RainDrop® Digital PCR, as well as the ThunderStorm® and ThunderBolts™ Next-Generation Sequencing Enrichment Systems through its international sales and service operations, as well as a global network of distributors and commercial service providers. Both technology platforms have been recognized by The Scientist as Top 10 Innovations with the RainDrop System winning the award in 2014 and the ThunderStorm System winning the award in 2011.